- Who can participate: Adults aged 18-65 with a diagnosis of type 2 diabetes, who are currently on stable medication regimens, may be eligible to participate. Exclusion criteria include individuals with type 1 diabetes or those with a history of severe hypoglycemia.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular monitoring of blood sugar levels, and participants will be required to maintain their current diabetes management plan.

